Second phase of clinical trial for promising COVID-19 drug begins
May 15, 2020
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.
Don’t let COVID-19 keep you from getting stroke care
May 13, 2020
Even during the COVID-19 pandemic, patients should never hesitate to call an ambulance if they have signs of a stroke
Cognition and gait speed often decline together, study shows
May 4, 2020
A study published by UT Health San Antonio researchers found that thinking and walking often parallel each other in determining a person’s health trajectory.
FDA gives emergency authorization to COVID-19 drug
May 4, 2020
Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 in a randomized clinical trial.
Remdesivir showing success in combating COVID-19
April 30, 2020
Early results of a COVID-19 treatment study being conducted in San Antonio shows a faster recovery time and fewer deaths for patients.
Scientists research a solution to the metabolic crisis
April 27, 2020
“Millions of people consume too much food, while millions of others are in poverty and subsist on too little food. We are studying what happens at the molecular level in both situations with a goal of developing a drug to intervene,” said Dr. Madesh Muniswamy.
